Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Phys Med ; 119: 103307, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38325221

RESUMO

PURPOSE: Radiotherapy outcome modelling often suffers from class imbalance in the modelled endpoints. One of the main options to address this issue is by introducing new synthetically generated datapoints, using generative models, such as Denoising Diffusion Probabilistic Models (DDPM). In this study, we implemented DDPM to improve performance of a tumor local control model, trained on imbalanced dataset, and compare this approach with other common techniques. METHODS: A dataset of 535 NSCLC patients treated with SBRT (50 Gy/5 fractions) was used to train a deep learning outcome model for tumor local control prediction. The dataset included complete treatment planning data (planning CT images, 3D planning dose distribution and patient demographics) with sparsely distributed endpoints (6-7 % experiencing local failure). Consequently, we trained a novel conditional 3D DDPM model to generate synthetic treatment planning data. Synthetically generated treatment planning datapoints were used to supplement the real training dataset and the improvement in the model's performance was studied. Obtained results were also compared to other common techniques for class imbalanced training, such as Oversampling, Undersampling, Augmentation, Class Weights, SMOTE and ADASYN. RESULTS: Synthetic DDPM-generated data were visually trustworthy, with Fréchet inception distance (FID) below 50. Extending the training dataset with the synthetic data improved the model's performance by more than 10%, while other techniques exhibited only about 4% improvement. CONCLUSIONS: DDPM introduces a novel approach to class-imbalanced outcome modelling problems. The model generates realistic synthetic radiotherapy planning data, with a strong potential to increase performance and robustness of outcome models.


Assuntos
Bisacodil/análogos & derivados , Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Humanos , Carcinoma Pulmonar de Células não Pequenas/diagnóstico por imagem , Carcinoma Pulmonar de Células não Pequenas/radioterapia , Difusão , Neoplasias Pulmonares/diagnóstico por imagem , Neoplasias Pulmonares/radioterapia
2.
Phys Med Biol ; 69(4)2024 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-38241726

RESUMO

Objective. High-resolution magnetic resonance imaging (MRI) can enhance lesion diagnosis, prognosis, and delineation. However, gradient power and hardware limitations prohibit recording thin slices or sub-1 mm resolution. Furthermore, long scan time is not clinically acceptable. Conventional high-resolution images generated using statistical or analytical methods include the limitation of capturing complex, high-dimensional image data with intricate patterns and structures. This study aims to harness cutting-edge diffusion probabilistic deep learning techniques to create a framework for generating high-resolution MRI from low-resolution counterparts, improving the uncertainty of denoising diffusion probabilistic models (DDPM).Approach. DDPM includes two processes. The forward process employs a Markov chain to systematically introduce Gaussian noise to low-resolution MRI images. In the reverse process, a U-Net model is trained to denoise the forward process images and produce high-resolution images conditioned on the features of their low-resolution counterparts. The proposed framework was demonstrated using T2-weighted MRI images from institutional prostate patients and brain patients collected in the Brain Tumor Segmentation Challenge 2020 (BraTS2020).Main results. For the prostate dataset, the bicubic interpolation model (Bicubic), conditional generative-adversarial network (CGAN), and our proposed DDPM framework improved the noise quality measure from low-resolution images by 4.4%, 5.7%, and 12.8%, respectively. Our method enhanced the signal-to-noise ratios by 11.7%, surpassing Bicubic (9.8%) and CGAN (8.1%). In the BraTS2020 dataset, the proposed framework and Bicubic enhanced peak signal-to-noise ratio from resolution-degraded images by 9.1% and 5.8%. The multi-scale structural similarity indexes were 0.970 ± 0.019, 0.968 ± 0.022, and 0.967 ± 0.023 for the proposed method, CGAN, and Bicubic, respectively.Significance. This study explores a deep learning-based diffusion probabilistic framework for improving MR image resolution. Such a framework can be used to improve clinical workflow by obtaining high-resolution images without penalty of the long scan time. Future investigation will likely focus on prospectively testing the efficacy of this framework with different clinical indications.


Assuntos
Bisacodil/análogos & derivados , Imageamento por Ressonância Magnética , Modelos Estatísticos , Masculino , Humanos , Razão Sinal-Ruído , Encéfalo/diagnóstico por imagem , Processamento de Imagem Assistida por Computador/métodos
3.
Med Phys ; 51(3): 1847-1859, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37646491

RESUMO

BACKGROUND: Daily or weekly cone-beam computed tomography (CBCT) scans are commonly used for accurate patient positioning during the image-guided radiotherapy (IGRT) process, making it an ideal option for adaptive radiotherapy (ART) replanning. However, the presence of severe artifacts and inaccurate Hounsfield unit (HU) values prevent its use for quantitative applications such as organ segmentation and dose calculation. To enable the clinical practice of online ART, it is crucial to obtain CBCT scans with a quality comparable to that of a CT scan. PURPOSE: This work aims to develop a conditional diffusion model to perform image translation from the CBCT to the CT distribution for the image quality improvement of CBCT. METHODS: The proposed method is a conditional denoising diffusion probabilistic model (DDPM) that utilizes a time-embedded U-net architecture with residual and attention blocks to gradually transform the white Gaussian noise sample to the target CT distribution conditioned on the CBCT. The model was trained on deformed planning CT (dpCT) and CBCT image pairs, and its feasibility was verified in brain patient study and head-and-neck (H&N) patient study. The performance of the proposed algorithm was evaluated using mean absolute error (MAE), peak signal-to-noise ratio (PSNR) and normalized cross-correlation (NCC) metrics on generated synthetic CT (sCT) samples. The proposed method was also compared to four other diffusion model-based sCT generation methods. RESULTS: In the brain patient study, the MAE, PSNR, and NCC of the generated sCT were 25.99 HU, 30.49 dB, and 0.99, respectively, compared to 40.63 HU, 27.87 dB, and 0.98 of the CBCT images. In the H&N patient study, the metrics were 32.56 HU, 27.65 dB, 0.98 and 38.99 HU, 27.00, 0.98 for sCT and CBCT, respectively. Compared to the other four diffusion models and one Cycle generative adversarial network (Cycle GAN), the proposed method showed superior results in both visual quality and quantitative analysis. CONCLUSIONS: The proposed conditional DDPM method can generate sCT from CBCT with accurate HU numbers and reduced artifacts, enabling accurate CBCT-based organ segmentation and dose calculation for online ART.


Assuntos
Bisacodil/análogos & derivados , Processamento de Imagem Assistida por Computador , Tomografia Computadorizada de Feixe Cônico Espiral , Humanos , Processamento de Imagem Assistida por Computador/métodos , Tomografia Computadorizada de Feixe Cônico , Tomografia Computadorizada por Raios X , Modelos Estatísticos , Planejamento da Radioterapia Assistida por Computador/métodos
4.
Biomed Res ; 37(1): 13-20, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26912136

RESUMO

The purpose of this study was to clarify the mode of desacetyl bisacodyl (DAB)-induced secretory action in intestinal tissues using an Ussing chamber assay. DAB is the active metabolite of the laxative bisacodyl. In mucosal-submucosal preparations, mucosal application of DAB induced a transient decrease followed by subsequent increases in short-circuit current and tissue conductance in a concentration-dependent manner. DAB-induced responses occurred from the middle colon to the rectal segment but not in the proximal colon. Moreover, these responses were not observed under chloride (Cl(-))-free conditions or in the presence of DAB on the serosal side of the mucosalsubmucosal specimens. Treatment with tetrodotoxin had no effect on the DAB-induced responses; however, mucosal treatment with a COX inhibitor piroxicam resulted in the elimination of responses. These results suggest that DAB may contribute to the laxative action by inducing Cl(-) secretion which is associated with the COX signaling pathway. This study also demonstrated that the DAB target molecule is present on the mucosal side from the middle colon to the rectal segment.


Assuntos
Bisacodil/análogos & derivados , Cloretos/metabolismo , Colo/metabolismo , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Reto/metabolismo , Potenciais de Ação/efeitos dos fármacos , Animais , Bisacodil/farmacologia , Colo/fisiologia , Eletrólitos/metabolismo , Fenômenos Eletrofisiológicos/efeitos dos fármacos , Masculino , Ratos , Reto/fisiologia
5.
Drug Metab Pharmacokinet ; 26(5): 458-64, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21697613

RESUMO

The aim of this study was to determine whether administration of the prodrugs bisacodyl (Bisa) and sodium picosulfate (SPS) leads to excretion of their common active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), in breast milk. Two groups of 8 healthy lactating women who had stopped breast feeding received multiple doses of Bisa or SPS. Plasma, urine, and breast milk were collected and concentrations of free and total BHPM were determined using validated liquid chromatography/mass spectrometry methods. BHPM remained below the limits of detection in breast milk following single- and multiple-dose administration of Bisa and SPS. First, BHPM plasma concentrations were observed after a lag time of about 3 to 4 h and 4 to 5 h following Bisa and SPS administration, respectively. C(max) was attained approximately 5 h after dosing of Bisa and 9 h after dosing of SPS. BHPM did not accumulate after multiple administrations of Bisa and only slightly accumulated following multiple doses of SPS. About 12% and 13% of Bisa and SPS was excreted as BHPM into urine at steady state. BHPM, the active moiety of Bisa and SPS, was not excreted into human breast milk. Hence, use of Bisa or SPS to treat constipation of breast-feeding women is considered well tolerated with regard to exposing infants to BHPM via breast milk.


Assuntos
Bisacodil/análogos & derivados , Bisacodil/farmacocinética , Leite Humano/metabolismo , Picolinas/farmacocinética , Pró-Fármacos/farmacocinética , Adulto , Catárticos/metabolismo , Catárticos/uso terapêutico , Cromatografia Líquida , Citratos , Constipação Intestinal/tratamento farmacológico , Feminino , Humanos , Lactação , Espectrometria de Massas , Leite Humano/química , Compostos Organometálicos
6.
Biochem J ; 317 ( Pt 2): 605-11, 1996 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-8713092

RESUMO

The influence of DNase I binding to Ca-ATP-G-actin and of Ca2+/Mg2+ and ATP/ADP exchange on the conformation of G-actin were investigated by measuring the fluorescence of dansyl cadaverine (DC) conjugated to Gln41 in subdomain 2 of the protein. Fluorescence resonance energy transfer (FRET) between this probe and N-[4-(dimethylamino)-3,5-dinitrophenyl]maleimide (DDPM) attached to Cys374 in subdomain 1 was also measured. Contrary to an earlier report [dos Remedios, Kiessling and Hambly (1994) in Synchrotron Radiation in the Biosciences (Chance, B., Deisenhofer, J., Ebashi, S., Goodhead, D. T., Helliwell, J. R., Huxley, H. E., Iizuka, T., Kirz, J., Mitsui, T., Rubenstein, E. et al., eds.), pp. 418-425, Oxford University Press, Oxford], the distance between these probes did not change significantly when DNase I was bound to actin. A small but reproducible increase in the quantum yield and a blue shift of the DC fluorescence maximum were observed when bound Ca2+ was replaced by Mg2+. A large increase (about 70%) in the quantum yield and an approx. 12 nm blue shift of the emission spectrum occurred when ATP in Mg-G-actin was replaced by ADP. These changes were not accompanied by any significant change in the FRET distance between the dansyl donor and DDPM acceptor probes. A substantial change in the fluorescence of DC-actin was observed after proteolytic removal of the last three residues of actin, in accordance with earlier evidence suggesting that there is a conformational coupling between subdomain 2 and the C-terminal segment in subdomain 1 of actin. The results are discussed in relation to recently published data obtained with another fluorescent probe and to earlier observations based on limited cleavage using proteolytic enzymes.


Assuntos
Actinas/química , Desoxirribonuclease I/química , Actinas/metabolismo , Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/química , Sítios de Ligação , Bisacodil/análogos & derivados , Bisacodil/química , Cadaverina/análogos & derivados , Cadaverina/química , Cátions Bivalentes/farmacologia , Desoxirribonuclease I/metabolismo , Transferência de Energia , Ligantes , Maleimidas/química , Modelos Moleculares , Ligação Proteica , Conformação Proteica/efeitos dos fármacos , Deleção de Sequência , Espectrometria de Fluorescência/métodos
7.
Biochim Biophys Acta ; 1202(1): 92-8, 1993 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-8373830

RESUMO

Bovine cardiac troponin C (cTnC) has cysteine residues located in the non-functional Ca(2+)-binding loop I (Cys-35) and at the N-terminal end of the central helix (Cys-84) near site II, the regulatory Ca(2+)-binding site. Recently, we reported that the excimer fluorescence resulting from the dimerization of adjacent pyrene groups attached to the two Cys residues is reduced by Ca2+ binding to site II (Liou, Y.-M. and Fuchs, F. (1992) Biophys. J. 61, 892-901). This result would suggest that Ca2+ binding causes a separation of the two Cys residues, a conclusion at variance with predictions from molecular modeling studies (Herzberg, O., Moult, J. and James, M.N.G. (1986) J. Biol. Chem. 261, 2638-2644). Alternatively, the reduction in excimer fluorescence could be accounted for by an immobilization of the pyrene attached to Cys-84 by a Ca(2+)-induced hydrophobic pocket. To arrive at a more definitive interpretation of these experiments, we carried out steady-state fluorescence resonance energy-transfer measurements of the Cys35-Cys84 distance. We used three different donor-acceptor pairs: 2-(4'-(iodoacetamido)anilino) naphthalene-6-sulfonic acid (IAANS) and 4-dimethylamino-phenylazophenyl-4-maleimide (DABMI), IAANS and N-(4-(dimethyl-amino)-3,5-dinitrophenyl) maleimide (DDPM), and 5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid (IAEDANS) and DDPM. At pCa 8.0, the distances were 23.8, 21.0, and 22.0 A with the donor-acceptor pairs, IAANS-DABMI, IAANS-DDPM and IAEDAN-DDPM, respectively. At pCa 4.0, the distances were 25.8, 24.1 and 21.2 A. The distances at pCa 8 and pCa 4.0 were not significantly altered when labeled cTnC was complexed with cardiac troponin I (cTnI). Thus, Ca2+ has little, if any, effect on the Cys35-Cys84 distance. These results are consistent with a model in which Ca2+ binding induces a separation of helices B and C from helix D, without any relative movement of the two N-terminal Ca(2+)-binding domains.


Assuntos
Cisteína/química , Troponina/química , Adenosina Trifosfatases/metabolismo , Animais , Bisacodil/análogos & derivados , Cálcio/farmacologia , Bovinos , Ativação Enzimática/efeitos dos fármacos , Ventrículos do Coração , Matemática , Miocárdio/metabolismo , Naftalenossulfonatos , Espectrometria de Fluorescência , Troponina/isolamento & purificação , Troponina/metabolismo , Troponina C , p-Dimetilaminoazobenzeno/análogos & derivados
8.
Jpn J Pharmacol ; 59(1): 1-5, 1992 May.
Artigo em Inglês | MEDLINE | ID: mdl-1507649

RESUMO

Sodium picosulfate, a laxative, was biotransformed to 4,4'-dihydroxydiphenyl-(2 pyridyl)-methane by intestinal flora that produced a novel sulfotransferase (not sulfatase). The biotransformation was activated by adding phenolic compounds such as phenol, acetaminophen and flavonoids. The enzyme activity related to this biotransformation was the highest in the contents of the caecum region of the intestine. The enzyme activity was 3.0 mumole/hr/g wet feces in humans and 0.75 in rats (pH 8.0). The optimal pH was 9.0.


Assuntos
Bisacodil/análogos & derivados , Catárticos/farmacocinética , Intestinos/microbiologia , Picolinas/farmacocinética , Sulfotransferases/metabolismo , Acetaminofen/farmacologia , Animais , Biotransformação , Bisacodil/farmacocinética , Carboxilesterase , Hidrolases de Éster Carboxílico/metabolismo , Citratos , Eubacterium/enzimologia , Fezes/química , Flavonoides/farmacologia , Humanos , Concentração de Íons de Hidrogênio , Intestinos/enzimologia , Masculino , Compostos Organometálicos , Fenóis/metabolismo , Fenóis/farmacologia , Ratos , Ratos Endogâmicos , Sulfatases/metabolismo
9.
Ther Drug Monit ; 12(1): 105-10, 1990 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2406997

RESUMO

Captopril is an orally active inhibitor of angiotensin-converting enzyme. A rapid, accurate, and sensitive high-performance chromatography (HPLC) method is described for measuring plasma concentrations of captopril. Captopril was stabilized by forming an adduct with p-bromophenacyl bromide. This adduct was measured by HPLC using a C-18 reverse-phase column and monitoring the column effluent by ultraviolet absorption at 260 nm. The method proved to be linear in the clinical range of 10-1,000 ng/ml. The plasma levels of captopril in a young patient given a small oral dose were determined by this method.


Assuntos
Captopril/sangue , Acetofenonas , Bisacodil/análogos & derivados , Cromatografia Líquida de Alta Pressão , Cromatografia em Camada Fina , Humanos , Indicadores e Reagentes , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Solventes , Espectrofotometria Ultravioleta
10.
Protein Seq Data Anal ; 1(2): 103-6, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3447159

RESUMO

Jack bean urease is inactivated by the modification of about one cysteine residue per subunit with N-ethylmaleimide (NEM) or other thiol titrant. The location of this cysteine residue was identified. After blocking the unessential thiol groups with NEM, the essential cysteine was labeled with N-(4-dimethylamino-3,5-dinitrophenyl)maleimide (DDPM). The DDPM-labeled protein was cleaved with cyanogen bromide and a DDPM-fragment was purified by gel filtration and ion exchange chromatography. Amino-terminal amino acid sequence of the DDPM-labeled fragment corresponded to that of a cyanogen bromide fragment of urease, VCHHLDREIPEDLAFAHSRIRKKTIAAEDVLNDIGAISIISSDSQAM. The second residue, Cys-592 in native urease, was labeled with DDPM. Fluoride ion, which competitively inhibits urease activity, protected urease from inactivation by NEM. The dissociation constant of fluoride ion obtained from the rate of inactivation with NEM was essentially identical to both the kinetically and spectrophotometrically determined dissociation constants. These suggest that the essential cysteine is at or near the active site.


Assuntos
Plantas/enzimologia , Urease , Sequência de Aminoácidos , Bisacodil/análogos & derivados , Cisteína , Fabaceae/enzimologia , Cinética , Dados de Sequência Molecular , Fragmentos de Peptídeos/isolamento & purificação , Plantas Medicinais , Urease/antagonistas & inibidores , Urease/metabolismo
11.
Biochim Biophys Acta ; 872(1-2): 76-82, 1986 Jul 25.
Artigo em Inglês | MEDLINE | ID: mdl-3089284

RESUMO

Intramonomer fluorescence resonance energy transfer between the donor epsilon-ATP bound to the nucleotide site and the acceptor N-(4-dimethylamino-3,5-dinitrophenyl)maleimide (DDPM) or 4-dimethylaminophenyl-azophenyl-4'-maleimide bound to Cys-10 in G-actin was measured. The donor-acceptor distance was calculated to be about 40 A. The intermonomer energy transfer in F-actin occurring between epsilon-ADP and DABMI was also measured. The radial coordinate of Cys-10 was calculated to be 25 A based on the helical symmetry of F-actin and the recently calculated radial coordinate of the nucleotide binding site in F-actin i.e. 25 A (Miki, M., Hambly, B. and dos Remedios, C.G. (1986) Biochim. Biophys. Acta 871, 137-141). (The assumption has been made in calculating these distances that the energy donor and acceptor rotate rapidly relative to the fluorescence lifetime.) Corresponding distances separating the donor nucleotide in one monomer from acceptors on Cys-10 in the first and second nearest neighbours in F-actin are 39-40 A and 41-43 A.


Assuntos
Actinas/metabolismo , Cistina , Nucleotídeos/metabolismo , Sítios de Ligação , Bisacodil/análogos & derivados , Bisacodil/metabolismo , Transferência de Energia , Matemática , Espectrometria de Fluorescência , Espectrofotometria Ultravioleta , p-Dimetilaminoazobenzeno/análogos & derivados , p-Dimetilaminoazobenzeno/metabolismo
12.
Carcinogenesis ; 7(7): 1155-9, 1986 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-3087646

RESUMO

The effects of antioxidants on mammary gland carcinogenesis pretreated with 7,12-dimethylbenz[a]anthracene (DMBA) in female Sprague-Dawley rats were examined. The antioxidants used were butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), sodium L-ascorbate, alpha-tocopherol, ethoxyquin and p,p'-diaminodiphenylmethane (DDPM), which is an inhibitor of carcinogenesis in the liver, kidney and urinary bladder. Female Sprague-Dawley rats of 50 days old were treated with 2.5 mg/100 g body weight of DMBA, and from 1 week later were given diet supplemented with 1% BHA, 0.7% BHT, 5% sodium L-ascorbate, 1.5% alpha-tocopherol, 0.5% ethoxyquin or 0.1% DDPM for 33 weeks and then killed. The incidences of mammary tumors, carcinomas and fibroadenomas in DMBA-treated animals were reduced by diet containing BHA or ethoxyquin. Diet containing BHT or DDPM inhibited the induction of only fibroadenomas. The incidence of ear duct tumors in DMBA-treated animals was reduced by diet containing BHT, alpha-tocopherol or ethoxyquin.


Assuntos
9,10-Dimetil-1,2-benzantraceno , Antioxidantes/farmacologia , Bisacodil/farmacologia , Cresóis/farmacologia , Neoplasias da Orelha/induzido quimicamente , Neoplasias Mamárias Experimentais/induzido quimicamente , Animais , Ácido Ascórbico/farmacologia , Bisacodil/análogos & derivados , Hidroxianisol Butilado/farmacologia , Hidroxitolueno Butilado/farmacologia , Transformação Celular Neoplásica/efeitos dos fármacos , Dieta , Etoxiquina/farmacologia , Feminino , Ratos , Ratos Endogâmicos , Vitamina E/farmacologia
13.
Eur J Pharmacol ; 117(2): 215-22, 1985 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-4076344

RESUMO

The effect of the diphenolic laxatives bisacodyl and deacetylbisacodyl on mucus secretion and fluid, sodium and potassium net transport was studied in rat colon perfused in vivo. Mucus output in the effluent was determined as total protein-bound hexose. Deacetylbisacodyl was more potent than the parent compound and was used to investigate dose-response relationships. At a low concentration (0.1 mg/dl), mucus and potassium secretion were stimulated whereas sodium and fluid absorption were inhibited, or converted to secretion, only at higher concentrations (0.5-3.0 mg/dl). All effects were dose-dependent and reversible within 1 h. With longer lasting perfusion of deacetylbisacodyl, mucus appeared in two peaks, one initial peak and another after 4 h. The late peak contained newly synthetized glycoproteins as indicated by the incorporation of intravenously injected [14C]galactose. It is concluded that stimulation of mucus secretion and synthesis contributes to the laxative action of bisacodyl. The effects of low versus high concentrations suggests that part of the potassium secretion is due to mucus release.


Assuntos
Bisacodil/farmacologia , Colo/efeitos dos fármacos , Cresóis/farmacologia , Eletrólitos/metabolismo , Muco/efeitos dos fármacos , Animais , Bisacodil/análogos & derivados , Colo/metabolismo , Relação Dose-Resposta a Droga , Feminino , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Muco/metabolismo , Perfusão , Potássio/metabolismo , Ratos , Ratos Endogâmicos , Sódio/metabolismo
14.
Acta Pharmacol Toxicol (Copenh) ; 51(4): 377-87, 1982 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6897480

RESUMO

Phenolphthalein (PHEN), desacetylbisacodyl (DES) and oxyphenisatin (OXY) were incubated with everted sacs of the rat jejunum and stripped descending colon; the mucosal and serosal fluid were analysed with respect to free and conjugated diphenol by means of HPLC. Conjugates were measured as the amount of free diphenol in completely hydrolyzed samples less the amount before hydrolysis. A study with double-sided administration of PHEN revealed that diphenol uptake from and conjugate output to both sides followed a rectilinear course for 15-90 min. A standard incubation time of 60 min. was chosen for the subsequent experiments, in which the diphenols were administered at the mucosal side at a low and a high concentration. Diphenol uptake, i.e. the amount of free diphenol administered less the amount recovered at the mucosal side, varied in an order (PHEN greater than DES greater than OXY) which seems to be inversely related to the order of water solubility of the compounds. Tissue accumulation and conjugate output relative to uptake varied with the dose, and from one compound to another. At low initial concentration (20 nmol/ml), the compounds were transferred to the jejunal and colonic serosal fluid almost entirely as conjugates (greater than or equal to 95%); the transfer rates followed, qualitatively, the same order as above. In jejunum, more conjugates were released to the mucosal than to the serosal side; in colon the distribution was reversed. Increasing the dose to 100 nmol/ml caused a corresponding increase in uptake, but relative output decreased and tissue accumulation increased; thus demonstrating capacity limitation. With PHEN, the ratio of conjugated:free diphenol on the serosal side remained essentially unchanged; with DES in particular, but also with OXY the ratio decreased. These findings may be interpreted to mean that in case of PHEN capacity limitation is linked to conjugate efflux, while DES and OXY may be poor substrates for glucuronide formation as well. Experiments with serosal side administration like the double-sided PHEN experiments verified the dissimilar conjugate distribution in jejunal and colonic sacs; the phenomenon is to some extent discussed in the text. Identity tests gave evidence that the conjugates were mainly monoglucuronides.


Assuntos
Catárticos/metabolismo , Mucosa Intestinal/metabolismo , Animais , Biotransformação , Bisacodil/análogos & derivados , Bisacodil/metabolismo , Colo/metabolismo , Técnicas In Vitro , Jejuno/metabolismo , Masculino , Acetato de Oxifenisatina/metabolismo , Fenolftaleínas/metabolismo , Ratos , Ratos Endogâmicos
15.
Acta Pharmacol Toxicol (Copenh) ; 51(2): 165-72, 1982 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-6896788

RESUMO

The ability of the laxative diphenols desacetylbisacodyl, oxyphenisatin, and phenolphthalein to inhibit growth and cause leakage of potassium ion from microbial cells in vitro was studied with 25 aerobic and 25 anaerobic bacterial strains. None of the aerobes, but some of the anaerobes showed growth inhibition. Potassium release assayed by flame photometry was observed in strains which showed growth inhibition, but also in other strains including anaerobes and aerobes. The highest antibacterial activity among the diphenols was observed with phenolphthalein and the least with desacetylbisacodyl; this relationship as noted for both growth inhibition and potassium release. Enzymatic hydrolysis of picosulphate to the free diphenol desacetylbisacodyl carried out by three strains of anaerobic bacteria was indicated by high pressure liquid chromatography.


Assuntos
Bactérias/efeitos dos fármacos , Catárticos/farmacologia , Intestinos/microbiologia , Bactérias/metabolismo , Bisacodil/análogos & derivados , Bisacodil/farmacologia , Humanos , Acetato de Oxifenisatina/farmacologia , Fenolftaleínas/farmacologia , Potássio/metabolismo
16.
J Chromatogr ; 222(3): 389-98, 1981 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-6894448

RESUMO

A method for the qualitative and quantitative simultaneous analysis of dioxyanthraquinone, desacetyl-Bisacodyl, phenolphthalein and Oxyphenisatin in human urine using gas chromatography-mass spectrometry (GC-MS) has been developed. The compounds were extracted from urine at pH 7.5 with diethyl ether using Extrelut extraction columns, followed by evaporation and trimethylsilylation. The method used electron beam ionization GC-MS employing a computer-controlled multiple-ion detector (mass fragmentography). The recovery from urine for the various compounds was between 80% and 100%. The detection limit for these compounds was in the range 0.01--0.05 micrograms/ml of urine. The method proved to be suitable for measuring urine concentrations for at least four days after administration of a single oral low therapeutic dose of the laxatives to sixteen healthy volunteers.


Assuntos
Catárticos/urina , Antraquinonas/urina , Bisacodil/análogos & derivados , Bisacodil/urina , Cromatografia Gasosa-Espectrometria de Massas/métodos , Glucuronidase , Humanos , Indicadores e Reagentes , Acetato de Oxifenisatina/urina , Fenolftaleínas/urina , Relação Estrutura-Atividade
17.
Acta Pharmacol Toxicol (Copenh) ; 48(1): 73-80, 1981 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-7223440

RESUMO

Bisacodyl (BIS), the parent diphenol (DES) and its sulphuric acid di-ester (picosulphate = PICO) were given by stomach tube to fasted rats at a dose of 3.1 mumol/100 g rat. Bile was sampled in the periods 0-6, 6-12 and 12-18 hrs after drug administration, and assayed for total diphenol (= free + conjugated) by HPLC. Mean fractions (% of dose +/- S.E.M.) excreted in 5 rats per compound and period were: BIS 74.0 +/- 4.7, 51.9 +/- 7.9 and 30.8 +/- 2.5; DES 41.2 +/-4.3, 46.8 +/- 4.7 and 25.1 +/- 2.5; PICO 9.0 +/- 0.9, 26.0 +/- 5.4 and 19.6 +/- 3.1. Only minor amounts were excreted as free diphenol. Urine samples taken by bladder puncture and assayed as above furthermore showed that the renal excretion of total diphenol was insignificant compared to the amounts excreted in bile. Practically no diphenol was present in urine 0-6 hrs after the administration of PICO. In experiments with BIS and DES at 0.85 mumol/100 g, total diphenol excreted in bile during 0-6 hrs was: BIS 67.1 +/- 2.6 (n = 5); DES: 55.4 +/- 3.0 (5). - The latency time for laxative effect was studied in groups of 10 unfasted rats per compound. cumulative time response curves showed that PICO caused diarrhoea more promptly at 0.85 mumol/100 g than either BIS or DES. In most rats, this delayed action of BIS and DES persisted also at 1.7 mumol/100 g. At 3.1 mumol/100 g, however, the majority of the rats reacted as promptly to these two compounds as to PICO. These results are discussed in relation to the biliary excretion experiments, and interpreted in terms of the relative importance at the different dose levels of: 1. The enterohepatic recirculated fraction, and 2. The non-absorbed fraction, which passes directly to the large intestine. For PICO, the latter fraction is the single determinant of the effect, which is triggered when the di-ester is being hydrolyzed to active diphenol in this part of the GI-tract.


Assuntos
Bisacodil/metabolismo , Catárticos/metabolismo , Cresóis/metabolismo , Defecação/efeitos dos fármacos , Circulação Êntero-Hepática , Picolinas/metabolismo , Animais , Bisacodil/administração & dosagem , Bisacodil/análogos & derivados , Bisacodil/farmacologia , Catárticos/administração & dosagem , Citratos , Relação Dose-Resposta a Droga , Intubação Gastrointestinal , Masculino , Compostos Organometálicos , Picolinas/administração & dosagem , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...